Fish oil won't save diabetics' hearts, research suggests

June 11, 2012 By Steven Reinberg, HealthDay Reporter
Fish oil won't save diabetics' hearts, research suggests
Experts say statins, not omega-3 supplements, lower cholesterol and improve cardiovascular health.

(HealthDay) -- People with type 2 diabetes who take omega-3 fatty acid supplements are neither helping nor harming their heart, a new study finds.

Omega-3 -- the type found in fish oil -- are hugely popular because research has linked them to a reduction in heart attacks, strokes and other cardiovascular problems. However, this study found no such benefits among people with type 2 , the researchers say.

"Previous studies had suggested that fish-oil supplements may have a modest benefit in these outcomes -- we did not find that at all," said researcher Dr. Hertzel Gerstein, a professor of medicine at McMaster University in Hamilton, Ontario, Canada.

Perhaps diabetics react differently to these supplements, or their risk of is so severe that a higher dose of the supplement would be needed to see an effect, Gerstein said.

"If you want to prevent cardiovascular disease, heart attacks and strokes, going out and buying omega-3 fatty acids is not going to do it," he said.

Type 2 diabetes, a condition linked to being overweight and marked by excess blood sugar, can lead to serious health problems, including heart disease and stroke, if it's uncontrolled.

The report was published June 11 online in the New England Journal of Medicine to coincide with the planned presentation of the study findings at a meeting of the American Diabetes Association in Philadelphia.

For the study, more than 12,500 people with type 2 diabetes or prediabetes and at high risk of cardiovascular events were randomly assigned to take a daily, 1-gram omega-3 fatty acid supplement or an inactive placebo. Over roughly six years, the researchers looked for deaths from cardiovascular causes.

The investigators found that taking an omega-3 fatty acid supplement had no effect on deaths from heart attack, stroke, other cardiovascular causes or any other cause.

The supplement did lower the levels of triglycerides, which may be an indicator of cardiovascular disease risk. But omega-3 fatty acid supplements had no effect on other lipids, such as "good" HDL cholesterol and "bad" LDL cholesterol, the researchers noted.

Dr. Joel Zonszein, professor of clinical medicine at Albert Einstein College of Medicine and director of the Clinical Diabetes Center at Montefiore Medical Center in New York City, said few studies have shown convincingly that treating high triglycerides or low HDL cholesterol improves cardiovascular outcomes.

"These lipoproteins, while good markers, do not appear to benefit when treated, particularly when compared with statins," he said.

"Treating LDL cholesterol, especially in patients with type 2 diabetes, is critical, and statins are best," Zonszein said.

Another expert, Dr. Spyros Mezitis, an endocrinologist at Lenox Hill Hospital in New York City, said patients ask about whether or not they should take omega-3 supplements to lower cholesterol.

"We tell them that statins are drugs that are proven to lower the bad cholesterol and are associated with a reduction in cardiovascular risks," he said.

There are patients who take fish oil on their own, Mezitis said. "We tell these patients they can continue taking , but it doesn't take the place of a statin," he said.

The study was funded by drug maker Sanofi.

Explore further: Omega-3 supplements no help against repeat heart trouble: review

More information:
For more information on diabetes, visit the American Diabetes Association.

Related Stories

Omega-3 supplements no help against repeat heart trouble: review

April 9, 2012
(HealthDay) -- Taking omega-3 fatty acid supplements won't protect against repeat heart attacks, strokes or other cardiovascular problems, a new analysis indicates.

No proof fibrate drugs reduce heart risk in diabetes patients on statins

August 10, 2011
Type 2 diabetes patients, who face higher risk of cardiovascular disease, often take a combination of medications designed to lower their LDL or "bad" cholesterol and triglyceride levels while raising their HDL or "good" ...

Omega-3 fatty acids don't improve heart's ability to relax and efficiently refill with blood

April 24, 2012
Over the past three decades, researchers have firmly established that the omega-3 fatty acids in fish oil, including eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), have healthy effects on the heart. Omega-3 fatty ...

Study debunks belief insulin puts people with diabetes at risk of heart disease

June 11, 2012
Researchers at McMaster University have discovered that long-term insulin use does not harm people with diabetes or pre-diabetes or put them at risk of heart attacks, strokes or cancer.

Recommended for you

Skimping on sleep may contribute to gestational diabetes

October 17, 2017
The amount of time spent sleeping in the United States has dropped significantly in the past twenty years with almost a quarter of women and 16 percent of men experiencing insufficient sleep. Now, a new study has found that ...

Diabetes pill might replace injection to control blood sugar

October 17, 2017
(HealthDay)— An injectable class of diabetes medication—called glucagon-like peptide-1 or GLP-1—might one day be available in pill form, research suggests.

Artificial pancreas performs well in clinical trial

October 16, 2017
During more than 60,000 hours of combined use of a novel artificial pancreas system, participants in a 12-week, multi-site clinical trial showed significant improvements in two key measures of well-being in people living ...

Omega-6 fats may help prevent type 2 diabetes

October 11, 2017
The risk of developing type 2 diabetes could be significantly reduced by eating a diet rich in omega-6 polyunsaturated fats, a new study suggests.

Where there's type 1 diabetes, celiac disease may follow

October 10, 2017
(HealthDay)—Parents of young children with type 1 diabetes need to be on the lookout for symptoms of another autoimmune condition—celiac disease, new research suggests.

Type 1 diabetes and the microbiota—MAIT cells as biomarkers and new therapeutic targets

October 10, 2017
Together with colleagues from AP-HP Necker–Enfants Malades Hospital in Paris, scientists from the Cochin Institute (CNRS / INSERM / Paris Descartes University) have discovered that the onset of type 1 diabetes is preceded ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.